Vaisala acquires Veriteq

Vaisala Pty Ltd
Friday, 11 June, 2010

Vaisala has strengthened its position in the life science market through the strategic acquisition of Veriteq Instruments Inc, a continuous monitoring system and data logger company based in Canada.

Veriteq is a provider of productised continuous monitoring systems and data logger solutions for the life science industry comprising pharmaceutical, biotechnological and medical device companies.

Life science is a focus area for Vaisala's Controlled Environments business, and the acquisition of Veriteq, with its life science emphasis, aligns with Vaisala's strategy.

"Vaisala is currently known as an instrument provider in the global pharmaceutical market. We want to strengthen our position by expanding our offering both to pharmaceutical and other life science customers. The Veriteq acquisition is a major step towards this goal, bringing additional know-how, a customer base, products and services to Vaisala," says Pirjo Kortteisto, Director of Cleanrooms and Chambers market segment.

Related News

CSIRO announces 300+ job cuts as part of restructure

CSIRO will need to reduce roles in its Research Units by 300–350 full-time equivalent staff...

Synchron raises $305m to advance brain–computer interfaces

Synchron's Stentrode BCI platform is billed as the world's first endovascular...

Air quality expert wins 2025 PM's Prize for Science

Distinguished Professor Lidia Morawska's work in the study of air quality provided vital...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd